Go to Top

Sientra (NASDAQ: SIEN) : DD and More

A few excerpts:


From Sientra’s (SIEN) 8-K filing from October 30th, 2015:

We continue to be well funded with a cash and cash equivalents balance of $148.9 million as of September 30, 2015. Earlier this week we paid in full our term loans totaling $24.5 million, and as a result the company has no outstanding debt obligations.

Insider Monkey:

At the end of the third quarter, a total of 10 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 67% from the second quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were upping their holdings considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Samuel Isaly’s OrbiMed Advisors has the biggest position in Sientra Inc (NASDAQ:SIEN), worth close to $30.2 million, corresponding to 0.3% of its total 13F portfolio. The second largest stake is held by Jacob Gottlieb of Visium Asset Management, with a $18 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Other hedge funds and institutional investors that are bullish contain Paul Orlin and Alex Porter’s Amici Capital, Israel Englander’s Millennium Management, and Craig A. Drill’s Craig Drill Capital.


As of now the particles found are only cotton and silica – big deal! All surgical wounds are impregnated with more cotton from one swab during a bloody operation, than a non- visible particle on an implant- and are cotton swabs banned? The other particle is Silica but Silica has been used in medicine for Centuries and in fact is still used to augment noses and in other reconstructions, for example in the disguise of pectus excavatum , chin augmentation , joint replacement and heart valves. It is the raw ingredient of silicone, so of course it must be present.


, ,